Specally
1 known investors
Specally develops AI software that enhances existing diagnostic tools like dermoscopes, reconstructing hyperspectral data from standard dermoscopy images to detect skin cancer and other skin conditions. It serves healthcare professionals and clinicians, supporting the workflow from early screening and triage to diagnosis and surgical margin definition.
AI & Machine LearningDigital HealthMedical Devices